ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Therapeutic Drug Carrier Systems
インパクトファクター: 2.9 5年インパクトファクター: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN 印刷: 0743-4863
ISSN オンライン: 2162-660X

巻:
巻 37, 2020 巻 36, 2019 巻 35, 2018 巻 34, 2017 巻 33, 2016 巻 32, 2015 巻 31, 2014 巻 30, 2013 巻 29, 2012 巻 28, 2011 巻 27, 2010 巻 26, 2009 巻 25, 2008 巻 24, 2007 巻 23, 2006 巻 22, 2005 巻 21, 2004 巻 20, 2003 巻 19, 2002 巻 18, 2001 巻 17, 2000 巻 16, 1999 巻 15, 1998 巻 14, 1997 巻 13, 1996 巻 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i2.10
30 pages

Caveolae—An Alternative Endocytotic Pathway for Targeted Drug Delivery

Gyorgy Bathori
Department of Physiology, Semmelweis University, Budapest, Hungary
Laszlo Cervenak
Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary
Istvan Karadi
Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary

要約

Caveolae are bottleshape-like invaginations of the plasma membrane. After internalization they are involved in endocytosis, transcytosis, potocytosis, and pinocytosis. Our recently expanded knowledge has made clear that various molecules and macromolecular complexes enter the cells after docking on caveolar receptors, before subsequent internalization of the caveolae. The internalization is initiated by the ligand receptor interaction. Folate, cholesterol, serum lipoproteins, and liposomes are among the most common examples. It is important to point out that, in contrast to the classic clathrin-dependent endocytosis, the caveolar internalization pathway seems to avoid the lysosomes. Internalized caveolae fuse with caveosomes, and the caveosomes deliver their contents into other subcellular (non-lysosomal) compartments. The bypass of the acidic and harmful milieu might be a major advantage for drug delivery via the caveolar pathway. Not all cell types have caveolae. Cells, where the Caveolin I protein is not expressed, do not develop caveolar invaginations. However, these cells have caveolar-equivalent plasma membrane domains, so-called "lipid rafts." Lipid rafts are assembled from the same lipid constituents and proteins as caveolae, but they are flat. Specific ligands may also dock on appropriate receptors of the raft domain. As a complication, certain types of ligand-covered raft receptors can migrate to clathrin-coated pits and get internalized via clathrin-coated vesicles. Nevertheless, suitable ligands or antibodies developed against proteins of the caveolar/raft domains may selectively direct the attached drug carrier to the less harmful caveolar/raft pathway. Thus, understanding of caveolar transport may help in the rational design of more effective drug carriers.


Articles with similar content:

Regulation of the Formation and External Transport of Secretory Immunoglobulins
Critical Reviews™ in Immunology, Vol.19, 1999, issue 5-6
F.-E. Johansen, H. Schjerven, I. N. Norderhaug, P. Brandtzaeg
Exosome Release by Primary B Cells
Critical Reviews™ in Immunology, Vol.29, 2009, issue 3
Alexander McLellan
Major Histocompatibility Complex (MHC) Class I Recognition by Natural Killer Cells
Critical Reviews™ in Immunology, Vol.17, 1997, issue 3-4
Marco Colonna, Christian Dohring
Molecular Mechanism of Opioid Analgesia
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 1
Thomas Efferth, Christian Zollner
Structural Plasticity of the Proteasome and Its Function in Antigen Processing
Critical Reviews™ in Immunology, Vol.21, 2001, issue 4
Maries van den Broek, Annalisa Macagno, Marcus Groettrup, Katrin Schwarz, Rita de Giuli, Gunter Schmidtke, Selina Khan